Sales – occupational activity
Pfizer Weighs Sale of Hospital Drugs Unit Amid Activist Pressure
Pfizer, hospital drugs unit, sale, activist investor, Starboard Value, Goldman Sachs
Eisai Slashes Leqembi Sales Forecast Amid Continued Launch Challenges
Eisai, Leqembi, Alzheimer’s disease, sales forecast, revenue expectations, Biogen, pharmaceutical industry
Merck Reports Strong Q3 Results but Lowers Full-Year Sales Guidance
Merck, Q3 Results, Full-Year Sales Guidance, Keytruda, Gardasil, Januvia, Winrevair, Capvaxive
Sanofi Workers Strike Over Consumer Health Unit Sale Amid Job Loss and Strategic Asset Concerns
Sanofi, strike, consumer health unit, sale, job losses, strategic assets, France, Doliprane, Opella, Clayton Dubilier & Rice
WuXi AppTec and WuXi Biologics Consider Asset Sales Amid BIOSECURE Act Scrutiny
WuXi AppTec, WuXi Biologics, BIOSECURE Act, asset sales, biotech industry, US-China relations
Pfizer Generates $2.88 Billion by Selling Off Hundreds of Millions of Haleon Shares
Pfizer, Haleon, share sale, pharmaceutical industry, financial news
Madrigal’s MASH Drug Rezdiffra Surpasses Q2 Sales Estimates
Madrigal Pharmaceuticals, Rezdiffra, MASH drug, Q2 earnings, sales estimates, FDA approval, commercial launch, NASH treatment
Novo Nordisk’s Wegovy Sales Shortfall: A Rare Setback for the Danish Drugmaker
Novo Nordisk, Wegovy, weight-loss drug, sales shortfall, stock performance, pharmaceutical industry
Accelerating Sales of Eisai and Biogen’s Alzheimer’s Drug Leqembi in Japan
Leqembi, Alzheimer’s drug, Eisai, Biogen, Japan, sales acceleration
Pfizer Considers Facility Sale Amid GSK’s Administrative Breach in South Korea
Pfizer, facility sale, GSK, administrative breach, South Korea, pharmaceutical industry